Innate Immunotherapeutics

File photo

A congressional probe of Rep. Chris Collins says there is "substantial reason" to believe the Clarence Republican may have been involved in insider trading on an Australian biotech stock, a violation of federal law.

WBFO News file photo

An investigation of Rep. Chris Collins has moved to the House Ethics Committee, after a review by the Office of Congressional Ethics. The person who filed the original complaint against the Clarence Republican said this shows there will be a deeper dive into the congressman's investments.